The Board of Directors of Ajanta Pharma is scheduled to meet on November 3, 2025, to consider an equity dividend. The meeting will also involve reviewing the unaudited financial results for the second quarter and half-year ended September 30, 2025. The record date for determining eligibility for the dividend has been set as November 10, 2025.
Dividend Consideration
Ajanta Pharma has announced that its Board of Directors will meet to consider a dividend on equity shares. The meeting is scheduled for November 3, 2025.
Financial Results Review
During the board meeting, the directors will also consider and take on record the unaudited financial results for the second quarter (Q2: Jul-Sep) and half-year, which ended on September 30, 2025.
Record Date
The company has fixed November 10, 2025, as the record date for determining shareholders’ eligibility for the 1st interim dividend for the financial year ending March 31, 2026, if declared.
Source: BSE
